Genomic data on GIST also show that mutations in other key signaling proteins, such as KRAS, BRAF, PIK3CA, PTEN could also mediate resistance to KIT/PDGFRA inhibitors [23–25]. The gene discussed is PTEN; the disease is gastrointestinal stromal tumor.